Phase 1Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Sponsored by Day One Biopharmaceuticals, Inc.
About this study
A Study of Emi-Le in Participants with Solid Tumors
Enrolling at this location
Northwestern University
Chicago, Illinois
I'm interestedThis study also enrolls at 25 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.